Fields 2008.
| Methods | Study design: Parallel‐group RCT Location: Akron Ohio, USA Number of centres: 1 Study period: October 2005 to March 2006 Funding source: Internal hospital funding |
|
| Participants | Setting: 24‐bed stroke, neurological and medical ICU Inclusion criteria: Any mechanically‐ventilated patient on the stroke/medical ICU intubated in the hospital for < 24 hours , no previous diagnosis of pneumonia Exclusion criteria: Patients with prior tracheotomies, younger than 18 years, AIDS secondary to immunocompromised systems, edentulous patients Number randomised: Not stated Number evaluated: Not stated Baseline characteristics: Not reported |
|
| Interventions |
Comparison: Toothbrushing 8‐hourly versus usual care Experimental group: Nurse brushed patient's teeth, tongue and hard palate for > 1 minute, then used toothette swab to swab patient's teeth, tongue and hard palate for > 1 minute, then apply moisturiser to lips. Mouth and pharynx were suctioned as needed using catheter which was replaced every 24 hours. Oral assessment every 12 hours. Oral care kit #2 provided for each participant, with worksheet #2 Control group: Usual care (unspecified) which could include up to 2 toothbrushings daily and toothette mouthcare as needed. Nurses used oral care kit #1 and worksheet #1 |
|
| Outcomes | 1. Incidence of VAP | |
| Notes | Sample size calculation: "Desired sample size was 200 ventilator dependent patients or 2000 ventilator days" Email sent to authors 3 September 2012 requesting numbers of patients treated. No reply received. Trial included in text as narrative only |
|
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Unclear risk | "..a plastic bin labelled 1‐350, containing sealed envelopes which each had either worksheet #1 or #2, plus information about the trial to give to families". No mention of whether envelopes were sequentially numbered. Method of sequence generation not described |
| Allocation concealment (selection bias) | Low risk | Allocation contained in sealed envelopes |
| Blinding of participants and personnel (performance bias) All outcomes | High risk | Not possible, both nurses and participants would have known allocated treatment |
| Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Outcome of VAP assessed by infection control nurse. Unclear whether this person was blinded to allocated treatment |
| Incomplete outcome data (attrition bias) All outcomes | High risk | The study neither reports the number of participants randomised nor the number analysed |
| Selective reporting (reporting bias) | High risk | No numerical data were reported in this paper. VAP incidence was not reported by treatment group or with any measure of variance |
| Other bias | Unclear risk | Insufficient information in the trial report to produce confidence in the methodology of this trial |